The First Decade with the Swedish Prescribed Drug Register – A Systematic Review of the Output in the Scientific Literature

Basic and Clinical Pharmacology and Toxicology

Volumn 119, Issue 5, 2016, Pages 464-469

  Wallerstedt, Susanna M ^a   Wettermark, Björn ^b,c   Hoffmann, Mikael ^d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STOCKHOLM COUNTY COUNCIL   (Sweden)

^d LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

HUMAN; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; REGISTER; STATISTICS AND NUMERICAL DATA; SWEDEN;

DRUG PRESCRIPTIONS; HUMANS; PHARMACOEPIDEMIOLOGY; PRESCRIPTION DRUGS; REGISTRIES; SWEDEN;

EID: 84971349322     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12613     Document Type: Article

References (29)

1. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 2005;58:323–37.
2. Takahashi Y, Nishida Y, Asai S. Utilization of health care databases for pharmacoepidemiology. Eur J Clin Pharmacol 2012;68:123–9.
3. Ferrer P, Ballarin E, Sabate M, Laporte JR, Schoonen M, Rottenkolber M et al. Sources of European drug consumption data at a country level. Int J Public Health 2014;59:877–87.
4. Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sorensen HT. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 2010;106:86–94.
5. Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U et al. The new Swedish Prescribed Drug Register – opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007;16:726–35.
6. Ludvigsson JF, Haberg SE, Knudsen GP, Lafolie P, Zoega H, Sarkkola C et al. Ethical aspects of registry-based research in the Nordic countries. Clin Epidemiol 2015;7:491–508.
7. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009;24:659–67.
8. National Board of Health and Welfare. Swedish prescribed drug register. Available at https://www.socialstyrelsen.se/statistik/statistikdatabas/lakemedel. (last accessed on 18 August 2015).
9. Wettermark B, Zoega H, Furu K, Korhonen M, Hallas J, Norgaard M et al. The Nordic prescription databases as a resource for pharmacoepidemiological research – a literature review. Pharmacoepidemiol Drug Saf 2013;22:691–9.
10. Rosen M. National Health Data Registers: a Nordic heritage to public health. Scand J Public Health 2002;30:81–5.
11. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011;11:450.
12. Johansson LA, Bjorkenstam C, Westerling R. Unexplained differences between hospital and mortality data indicated mistakes in death certification: an investigation of 1,094 deaths in Sweden during 1995. J Clin Epidemiol 2009;62:1202–9.
13. Cnattingius S, Ericson A, Gunnarskog J, Kallen B. A quality study of a medical birth registry. Scand J Soc Med 1990;18:143–8.
14. Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009;48:27–33.
15. Ludvigsson JF, Almqvist C, Bonamy AE, Ljung R, Michaelsson K, Neovius M et al. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol 2016;31:125–36.
16. Statistics Sweden. Longitudinal integration database for health insurance and labour market studies (LISA). Available at http://www.scb.se/en_/Services/Guidance-for-researchers-and-universities/SCB-Data/Longitudinal-integration-database-for-health-insurance-and-labour-market-studies-LISA-by-Swedish-acronym/#;. (last accessed on 3 May 2016).
17. Emilsson L, Lindahl B, Koster M, Lambe M, Ludvigsson JF. Review of 103 Swedish Healthcare Quality Registries. J Intern Med 2015;277:94–136.
18. Carlsson AC, Wandell P, Osby U, Zarrinkoub R, Wettermark B, Ljunggren G. High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden – a challenge for public health. BMC Public Health 2013;13:670.
19. Hayrinen K, Saranto K, Nykanen P. Definition, structure, content, use and impacts of electronic health records: a review of the research literature. Int J Med Inform 2008;77:291–304.
20. Fastbom J, Johnell K. National indicators for quality of drug therapy in older persons: the Swedish experience from the first 10 years. Drugs Aging 2015;32:189–99.
21. Anell A. The public-private pendulum–patient choice and equity in Sweden. N Engl J Med 2015;372:1–4.
22. Belfrage B, Koldestam A, Sjöberg C, Wallerstedt SM. Number of drugs in the medication list as an indicator of prescribing quality: a validation study of polypharmacy indicators in older hip fracture patients. Eur J Clin Pharmacol 2015;71:363–8.
23. Brilleman SL, Salisbury C. Comparing measures of multimorbidity to predict outcomes in primary care: a cross sectional study. Fam Pract 2013;30:172–8.
24. Wallerstedt SM, Belfrage B, Fastbom J. Association between drug-specific indicators of prescribing quality and quality of drug treatment: a validation study. Pharmacoepidemiol Drug Saf 2016;24:906–14.
25. Wallerstedt SM, Belfrage B, Koldestam A, Sjöberg C. [Concurrent validity of Swedish drug-specific indicators of prescribing quality] Läkartidningen. 2016;113: DSU4.
26. Dahlen E, Wettermark B, Bergstrom A, Jonsson EW, Almqvist C, Kull I. Medicine use and disease control among adolescents with asthma. Eur J Clin Pharmacol 2016;72:339–47.
27. Wettermark B. The intriguing future of pharmacoepidemiology. Eur J Clin Pharmacol 2013;69(Suppl 1):43–51.
28. Schneeweiss S. Developments in post-marketing comparative effectiveness research. Clin Pharmacol Ther 2007;82:143–56.
29. Suissa S. Statistical methods in pharmacoepidemiology: advances and challenges. Stat Methods Med Res 2009;18:3–6.